183 related articles for article (PubMed ID: 36900297)
1. Recurrent Esthesioneuroblastoma: Long-Term Outcomes of Salvage Therapy.
Ni G; Pinheiro-Neto CD; Iyoha E; Van Gompel JJ; Link MJ; Peris-Celda M; Moore EJ; Stokken JK; Gamez M; Choby G
Cancers (Basel); 2023 Feb; 15(5):. PubMed ID: 36900297
[TBL] [Abstract][Full Text] [Related]
2. Long-term oncologic outcomes in esthesioneuroblastoma: An institutional experience of 143 patients.
McMillan RA; Van Gompel JJ; Link MJ; Moore EJ; Price DL; Stokken JK; Van Abel KM; O'Byrne J; Giannini C; Chintakuntlawar A; Pinheiro Neto CD; Peris Celda M; Foote R; Choby G
Int Forum Allergy Rhinol; 2022 Dec; 12(12):1457-1467. PubMed ID: 35385606
[TBL] [Abstract][Full Text] [Related]
3. Consolidating the Hyams grading system in esthesioneuroblastoma - an individual participant data meta-analysis.
Vuong HG; Ngo TNM; Dunn IF
J Neurooncol; 2021 May; 153(1):15-22. PubMed ID: 33770323
[TBL] [Abstract][Full Text] [Related]
4. [New system combining Hyams grading system and modified Kadish stage to evaluate the progress of esthesioneuroblastoma].
Lai YY; Lin TJ; Jiang LJ; Deng J; Zuo KJ; Zhang Y; Shi JB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Jul; 33(7):599-602. PubMed ID: 31327194
[No Abstract] [Full Text] [Related]
5. Patterns of recurrence and disease progression in patients with positive-margin olfactory neuroblastoma following primary resection.
Bauman MMJ; Graves JP; Haller TJ; McMillan RA; Routman DM; Raghunathan A; Stokken JK; Link MJ; Moore EJ; Choby G; Van Gompel JJ
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38518294
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical Profiling and Staging in Esthesioneuroblastoma: A Single-Center Cohort Study and Systematic Review.
Henson JC; Cutler CC; Cole KL; Lucke-Wold B; Khan M; Alt JA; Karsy M
World Neurosurg; 2023 Feb; 170():e652-e665. PubMed ID: 36435382
[TBL] [Abstract][Full Text] [Related]
7. Extraprimary Local Recurrence of Esthesioneuroblastoma: Case Series and Literature Review.
Maina IW; Lehrich BM; Goshtasbi K; Su BM; Stubbs VC; Tong CCL; Kohanski MA; Lee JYK; Luu QC; Newman JG; Palmer JN; Adappa ND; Kuan EC
World Neurosurg; 2020 Dec; 144():e546-e552. PubMed ID: 32916346
[TBL] [Abstract][Full Text] [Related]
8. Prognostic utility of Hyams histological grading and Kadish-Morita staging systems for esthesioneuroblastoma outcomes.
Bell D; Saade R; Roberts D; Ow TJ; Kupferman M; DeMonte F; Hanna EY
Head Neck Pathol; 2015 Mar; 9(1):51-9. PubMed ID: 24806334
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Survival Outcomes and Treatment Experience of 64 Patients With Esthesioneuroblastoma.
Zeng Q; Tian Y; He Y; Xie Q; Ou L; Wang M; Chen W; Wei R
Front Oncol; 2021; 11():624960. PubMed ID: 33747939
[No Abstract] [Full Text] [Related]
10. Long-term outcome of esthesioneuroblastoma: hyams grade predicts patient survival.
Van Gompel JJ; Giannini C; Olsen KD; Moore E; Piccirilli M; Foote RL; Buckner JC; Link MJ
J Neurol Surg B Skull Base; 2012 Oct; 73(5):331-6. PubMed ID: 24083125
[TBL] [Abstract][Full Text] [Related]
11. Esthesioneuroblastoma and sinonasal undifferentiated carcinoma: impact of histological grading and clinical staging on survival and prognosis.
Miyamoto RC; Gleich LL; Biddinger PW; Gluckman JL
Laryngoscope; 2000 Aug; 110(8):1262-5. PubMed ID: 10942123
[TBL] [Abstract][Full Text] [Related]
12. Regional Recurrences and Hyams Grade in Esthesioneuroblastoma.
Ziai H; Yu E; Weinreb I; Perez-Ordonez B; Yao CMKL; Xu W; Yang D; Witterick IJ; Monteiro E; Gilbert RW; Irish JC; Gullane PJ; Goldstein DP; Ringash J; Bayley A; de Almeida JR
J Neurol Surg B Skull Base; 2021 Dec; 82(6):608-614. PubMed ID: 34745827
[No Abstract] [Full Text] [Related]
13. Comparison of Open and Endoscopic Approaches in the Resection of Esthesioneuroblastoma.
Barinsky GL; Azmy MC; Kilic S; Grube JG; Baredes S; Hsueh WD; Eloy JA
Ann Otol Rhinol Laryngol; 2021 Feb; 130(2):136-141. PubMed ID: 32627574
[TBL] [Abstract][Full Text] [Related]
14. Endoscopic endonasal resection of esthesioneuroblastoma: A single center experience of 24 patients.
Feng L; Fang J; Zhang L; Li H; Zhou B; Chen X; Li Y; Han D
Clin Neurol Neurosurg; 2015 Nov; 138():94-8. PubMed ID: 26310690
[TBL] [Abstract][Full Text] [Related]
15. Stereotactic radiosurgical salvage treatment for locally recurrent esthesioneuroblastoma.
Van Gompel JJ; Carlson ML; Pollock BE; Moore EJ; Foote RL; Link MJ
Neurosurgery; 2013 Mar; 72(3):332-9; discussion 339-40. PubMed ID: 23208068
[TBL] [Abstract][Full Text] [Related]
16. Metastatic esthesioneuroblastoma recurrence after 19 years of remission: A systematic review with case illustration.
Mozaffari K; Pradhan A; Yang I; Patel K; Vivas AC
J Neurol Sci; 2022 Nov; 442():120406. PubMed ID: 36081302
[TBL] [Abstract][Full Text] [Related]
17. Outcome and Optimal Treatment for Esthesioneuroblastoma in the Era of Intensity-Modulated Radiation Therapy: A Single-Center Experience.
Liu T; Sun Q; Qin W; Chen X; Hu Q
Cancer Manag Res; 2020; 12():8355-8362. PubMed ID: 32982429
[TBL] [Abstract][Full Text] [Related]
18. Exclusively endoscopic surgical resection of esthesioneuroblastoma: A systematic review.
Spielman DB; Liebowitz A; Grewal M; Safi C; Overdevest JB; Iloreta AM; Youngerman BE; Gudis DA
World J Otorhinolaryngol Head Neck Surg; 2022 Mar; 8(1):66-72. PubMed ID: 35619935
[TBL] [Abstract][Full Text] [Related]
19. [Primary experience and discussion on the treatment of esthesioneuroblastoma].
Jiang LJ; Lin TJ; Huang ZQ; Zuo KJ; Zhang Y; Shi JB; Lai YY
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2021 Jul; 56(7):719-723. PubMed ID: 34344098
[No Abstract] [Full Text] [Related]
20. Orbital invasion by Esthesioneuroblastoma: a comparative case series and review of literature.
Wu K; Avila SA; Bhuyan R; Matloob A; Del Signore AG; Hadjipanayis C; Chelnis J
Orbit; 2022 Feb; 41(1):1-14. PubMed ID: 33317383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
